Application no. and date | 98957255.7 (espacenet) (Federated) (European Patent Register), 19981110 | Patent/reg. no. and date | DK/EP 0969819, 20030305 | Publication date | 20000112 | Priority no. and date | | EP pub. no. and date |
EP 0969819 20000112 | Effective date | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | Applicant ref. no. | | Inventor | LÖVQVIST, Karin, AstraZeneca R&D Mölndal
S-431 83 Mölndal, SE, NORELAND, David, AstraZeneca Bulk Production, Sweden
S-151 85 Södertälje, SE, SUNDEN, Gunnel, AstraZeneca R&D Mölndal
S-431 83 Mölndal, SE, YMEN, Ingvar, AstraZeneca Bulk Production, Sweden
S-151 85 Södertälje, SE | Representative | | Opponent | | IPC Class | A61K 31/44, A61K 9/28, C07D 401/12 | Title | Ny krystalform af omeprazol | Int. application no. | SE1998002028 | Int. publication no. | WO1999008500 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|